2012
DOI: 10.2169/internalmedicine.51.6156
|View full text |Cite
|
Sign up to set email alerts
|

Hypereosinophilic Syndrome Associated with Simultaneous Intracardiac Thrombi, Cerebral Thromboembolism and Pulmonary Embolism

Abstract: The hypereosinophilic syndrome (HES) is a subcategory of idiopathic eosinophilia which is characterized by marked unexplained eosinophilia and evidence of tissue eosinophilia which leads to eosinophil-mediated organ damage. Cardiac and thromboembolic complications of HES are the common causes of mortality and morbidity. Here, we report a 54-year-old woman with HES who presented with simultaneously occurring cardiac thrombi, pulmonary embolism, and cerebrovascular thromboembolism.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 10 publications
(10 reference statements)
0
8
0
Order By: Relevance
“…In some reports regarding HES patients, neither warfarin nor heparin avoided fatal outcome once thrombosis had occurred, [8] but there are some successful cases with LMWH. [4,25] Though the standard care of DVT is LMWH followed by a vitamin K antagonist, in our case we initially chose a Factor Xa inhibitor, rivaroxaban, in the setting of thrombocytopenia and suspected DIC, since some literatures indicate that a Factor Xa inhibitor may cause fewer major bleeding events than warfarin or LMWH. [2628] After the use of steroid and rivaroxaban, the patient's EO followed with platelet count recovered and the swollen extremity progressively improved, but the fibrinogen level remained low.…”
Section: Discussionmentioning
confidence: 99%
“…In some reports regarding HES patients, neither warfarin nor heparin avoided fatal outcome once thrombosis had occurred, [8] but there are some successful cases with LMWH. [4,25] Though the standard care of DVT is LMWH followed by a vitamin K antagonist, in our case we initially chose a Factor Xa inhibitor, rivaroxaban, in the setting of thrombocytopenia and suspected DIC, since some literatures indicate that a Factor Xa inhibitor may cause fewer major bleeding events than warfarin or LMWH. [2628] After the use of steroid and rivaroxaban, the patient's EO followed with platelet count recovered and the swollen extremity progressively improved, but the fibrinogen level remained low.…”
Section: Discussionmentioning
confidence: 99%
“…In HES, recurrence of thrombosis even after reduced eosinophilia may be due to residual endothelial damage from prolonged eosinophilia, warfarin failure, or potentially eosinophilindependent mechanisms (Leon-Ferre et al 2013). The chronic suppressive treatment for eosinophilia should not be interrupted due to the risk of new thromboembolic events which can be life-threatening (Buyuktas et al 2012).…”
Section: Discussionmentioning
confidence: 99%
“… 1 Occasionally, LV thrombus can be found in patients with hypertrophic cardiomyopathy and hypereosinophilia. 14 , 15 It is often accompanied by peripheral vascular thromboembolic complications such as stroke, and thus has a high mortality and morbidity. 2 3 , 13 LV thrombi may be significantly reduced or even completely dissolved if timely and effective anticoagulant and/or antithrombotic therapy is administered.…”
Section: Discussionmentioning
confidence: 99%